Eosinophil
Granulocytus acidophilus
Also known as: eosinophilic granulocyte, acidophil, eos
A granulocyte with a bilobed nucleus and large orange-red granules (≈ 1–6% of leukocytes) specialised for killing helminth parasites and a major effector of allergic and asthmatic inflammation.
Overview
Eosinophils (≈ 12–15 µm) have a characteristically bilobed ("spectacle") nucleus and cytoplasm packed with large, refractile granules that stain bright orange-red with eosin. Each specific granule has a crystalloid core of major basic protein (MBP) surrounded by a matrix containing eosinophil cationic protein, eosinophil peroxidase and eosinophil-derived neurotoxin — all toxic to parasites and, unfortunately, to host epithelium. Eosinophils also make leukotriene C4, platelet-activating factor and cytokines.
They are produced in the marrow under the control of IL-5, circulate briefly (hours) and then reside in tissues — normally the lamina propria of the gut, and in disease the airways and skin — attracted by eotaxins (CCL11) and other chemokines. Helminths are far too large to be phagocytosed, so eosinophils bind IgE- or IgG-coated worms through Fc receptors and degranulate onto their surface (antibody-dependent cell-mediated cytotoxicity). In allergic disease, Th2 cytokines (IL-5, IL-4, IL-13) drive eosinophil recruitment in the late phase of the response, causing epithelial damage and airway remodelling in asthma.
- Location
Bone marrow, blood (briefly) and tissues, especially the gastrointestinal lamina propria, airways and skin.
Parts & subdivisions
- Specific granulesCrystalloid core of major basic protein; matrix with eosinophil cationic protein, eosinophil peroxidase and eosinophil-derived neurotoxin.
- Bilobed nucleusTwo lobes connected by a thin chromatin band.
Function
- Defence against multicellular parasites (helminths), mainly by degranulation (ADCC).
- Effector cell of the late phase of allergic reactions and asthma.
- Regulation of mast cells and tissue remodelling; phagocytosis of immune complexes.
- Physiology
Counts show diurnal variation (lowest in the morning when cortisol peaks); glucocorticoids cause rapid eosinopenia. Normal count 0.04–0.4 × 10⁹/L.
Clinical significance
Causes of eosinophilia
Allergic disease (asthma, atopic dermatitis, allergic rhinitis, drug reactions including DRESS), parasites (especially tissue-invasive helminths: Strongyloides, Toxocara, schistosomes, hookworm, Ascaris larval migration), neoplasms (Hodgkin lymphoma, eosinophilic leukaemia), vasculitis (eosinophilic granulomatosis with polyangiitis), adrenal insufficiency (lack of cortisol) and eosinophilic organ diseases (eosinophilic oesophagitis, hypereosinophilic syndrome with cardiac damage).
Asthma and anti-IL-5 therapy
Sputum eosinophils and Charcot–Leyden crystals (galectin-10) are features of eosinophilic asthma; monoclonal antibodies against IL-5 (mepolizumab) or its receptor (benralizumab) reduce exacerbations in severe eosinophilic asthma.
Compiled from standard anatomy and physiology references — see the Lymphatic & Immune System sources. For education only; not medical advice.